| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| C Sánchez-Carnerero Callado, N Núñez-Sánchez, S Casano, C Ferreiro-Ver. The potential of near infrared spectroscopy to estimate the content of cannabinoids in Cannabis sativa L.: A comparative study. Talanta. vol 190. 2018-10-29. PMID:30172491. |
cannabinoids are the main biologically active constituents of the cannabis genus, with a demonstrated medicinal value. |
2018-10-29 |
2023-08-13 |
Not clear |
| C Sánchez-Carnerero Callado, N Núñez-Sánchez, S Casano, C Ferreiro-Ver. The potential of near infrared spectroscopy to estimate the content of cannabinoids in Cannabis sativa L.: A comparative study. Talanta. vol 190. 2018-10-29. PMID:30172491. |
the aim of the present research was to develop a fast, economical, robust and environmentally friendly method based on nir technology that allow the quantification of the main cannabinoids present in cannabis sativa l. |
2018-10-29 |
2023-08-13 |
Not clear |
| Kristiina Leiman, Lorenzo Colomo, Sergio Armenta, Miguel de la Guardia, Francesc A Esteve-Turrilla. Fast extraction of cannabinoids in marijuana samples by using hard-cap espresso machines. Talanta. vol 190. 2018-10-29. PMID:30172516. |
fast extraction of cannabinoids in marijuana samples by using hard-cap espresso machines. |
2018-10-29 |
2023-08-13 |
Not clear |
| T Urban, J Hureau. [Cannabis and lung. What we know and everything we don't know yet]. Revue de pneumologie clinique. vol 73. issue 6. 2018-10-26. PMID:29126755. |
finally, cannabis smoke contains various cannabinoids, for example cannabidiol which also have anti-inflammatory and antifibrotic properties, with the unconfirmed hypothesis that these properties can partially modulate the deleterious action of cannabis smoke. |
2018-10-26 |
2023-08-13 |
Not clear |
| Ulf Meier, Franz Dussy, Eva Scheurer, Katja Mercer-Chalmers-Bender, Sarah Hangartne. Cannabinoid concentrations in blood and urine after smoking cannabidiol joints. Forensic science international. vol 291. 2018-10-26. PMID:30149280. |
cannabinoid concentrations in blood and urine after smoking cannabidiol joints. |
2018-10-26 |
2023-08-13 |
Not clear |
| Donald I Abram. The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. European journal of internal medicine. vol 49. 2018-10-25. PMID:29325791. |
the therapeutic effects of cannabis and cannabinoids: an update from the national academies of sciences, engineering and medicine report. |
2018-10-25 |
2023-08-13 |
Not clear |
| Donald I Abram. The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. European journal of internal medicine. vol 49. 2018-10-25. PMID:29325791. |
the national academies of sciences, engineering and medicine conducted a rapid turn-around comprehensive review of recent medical literature on the health effects of cannabis and cannabinoids. |
2018-10-25 |
2023-08-13 |
Not clear |
| Donald I Abram. The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. European journal of internal medicine. vol 49. 2018-10-25. PMID:29325791. |
the committee developed standard language to categorize the weight of evidence regarding whether cannabis or cannabinoids use for therapeutic purposes are an effective or ineffective treatment for the prioritized health endpoints of interest. |
2018-10-25 |
2023-08-13 |
Not clear |
| Donald I Abram. The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. European journal of internal medicine. vol 49. 2018-10-25. PMID:29325791. |
in the therapeutics chapter reviewed here, the report concluded that there was conclusive or substantial evidence that cannabis or cannabinoids are effective for the treatment of pain in adults; chemotherapy-induced nausea and vomiting and spasticity associated with multiple sclerosis. |
2018-10-25 |
2023-08-13 |
Not clear |
| Ran Abuhasira, Liat Shbiro, Yuval Landschaf. Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America. European journal of internal medicine. vol 49. 2018-10-25. PMID:29329891. |
medical use of cannabis and cannabinoids containing products - regulations in europe and north america. |
2018-10-25 |
2023-08-13 |
Not clear |
| Matthew R D Brown, W Paul Farquhar-Smit. Cannabinoids and cancer pain: A new hope or a false dawn? European journal of internal medicine. vol 49. 2018-10-25. PMID:29482740. |
the efficacy of cannabinoids seems to have been 'lost in translation' which may in part be related to using extracts of herbal cannabis rather than targeted selective full agonists at the cannabinoid cb1 and cb2 receptors. |
2018-10-25 |
2023-08-13 |
Not clear |
| Tae Yeon Kong, Ju-Hyun Kim, Dong Kyun Kim, Hye Suk Le. Synthetic cannabinoids are substrates and inhibitors of multiple drug-metabolizing enzymes. Archives of pharmacal research. vol 41. issue 7. 2018-10-24. PMID:30039377. |
synthetic cannabinoids, a new class of psychoactive substances, are potent agonists of cannabinoid receptors, which mimic the psychoactive effects of the principal psychoactive component of cannabis, ∆9-tetrahydrocannabinol. |
2018-10-24 |
2023-08-13 |
Not clear |
| Allegra Leghissa, Zacariah L Hildenbrand, Frank W Foss, Kevin A Schu. Determination of cannabinoids from a surrogate hops matrix using multiple reaction monitoring gas chromatography with triple quadrupole mass spectrometry. Journal of separation science. vol 41. issue 2. 2018-10-22. PMID:29094798. |
cannabinoids are the primary bioactive constituents of cannabis sativa and cannabis indica plants. |
2018-10-22 |
2023-08-13 |
Not clear |
| Talitha C Ford, Amie C Hayley, Luke A Downey, Andrew C Parrot. Cannabis: An Overview of its Adverse Acute and Chronic Effects and its Implications. Current drug abuse reviews. vol 10. issue 1. 2018-10-18. PMID:28707583. |
although the cannabinoid cannabidiol (cbd) has been shown to have positive health outcomes with its antioxidant, anticonvulsant, anti-inflammatory and neuroprotective properties, high-potency cannabis is particularly damaging due to its high tetrahydrocannabinol (thc), low cdb concentration. |
2018-10-18 |
2023-08-13 |
Not clear |
| John C Achenbach, Jessica Hill, Joseph P M Hui, Michael G Morash, Fabrice Berrue, Lee D Elli. Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on Zebrafish Larvae. Zebrafish. vol 15. issue 4. 2018-10-15. PMID:29634460. |
for decades, plant breeders have been breeding the cannabis plant to control for a desired ratio of the major cannabinoids. |
2018-10-15 |
2023-08-13 |
zebrafish |
| Allegra Leghissa, Zacariah L Hildenbrand, Kevin A Schu. A review of methods for the chemical characterization of cannabis natural products. Journal of separation science. vol 41. issue 1. 2018-10-09. PMID:28986974. |
presented here are reviewed analytical methods for the determination of cannabinoids (primarily) and terpenes (secondarily), the primary natural products of interest in cannabis plants. |
2018-10-09 |
2023-08-13 |
Not clear |
| Cristina Sempio, Karl B Scheidweiler, Allan J Barnes, Marilyn A Huesti. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry. Drug testing and analysis. vol 10. issue 3. 2018-10-01. PMID:28815938. |
prolonged urinary cannabinoid excretion in chronic frequent cannabis users confounds identification of recent cannabis intake that may be important in treatment, workplace, clinical, and forensic testing programs. |
2018-10-01 |
2023-08-13 |
Not clear |
| Cristina Sempio, Karl B Scheidweiler, Allan J Barnes, Marilyn A Huesti. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry. Drug testing and analysis. vol 10. issue 3. 2018-10-01. PMID:28815938. |
the method was utilized to analyze urine specimens collected during our controlled smoked, vaporized, and edible cannabis administration study to improve interpretation of urine cannabinoid test results. |
2018-10-01 |
2023-08-13 |
Not clear |
| Neera Khattar, Joanne C Routsolia. Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review. American journal of therapeutics. vol 25. issue 3. 2018-09-27. PMID:28953512. |
cannabinoid hyperemesis syndrome (chs) is a syndrome of cyclic vomiting associated with chronic cannabis use. |
2018-09-27 |
2023-08-13 |
Not clear |
| Joseph Habboushe, Ada Rubin, Haoming Liu, Robert S Hoffma. The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana Smokers in an Urban Public Hospital. Basic & clinical pharmacology & toxicology. vol 122. issue 6. 2018-09-27. PMID:29327809. |
the prevalence of cannabinoid hyperemesis syndrome among regular marijuana smokers in an urban public hospital. |
2018-09-27 |
2023-08-13 |
Not clear |